Allen JL, Hames RA, Mastroianni NM, Greenstein AE, et al. Evaluation of the matrix metalloproteinase 9 (MMP9) inhibitor Andecaliximab as an Anti-invasive therapeutic in Head and neck squamous cell carcinoma. Oral Oncol 2022;132:106008.
PMID: 35803110